Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia

Jiménez-Vicente C, Arribas I, Pomares H, Ramil G, Castaño-Diez S, Pérez-Valencia AI, Sturla AL, López-Guerra M, Martinez-Roca A, Zugasti I, Guijarro F, Cortés-Bullich A, Merchán B, Triguero A, Monge I, Tuca A, Oñate G, Garrido A, Sierra J, Arnan M, Esteve J, Díaz-Beyá M; Spanish CETLAM Group.